Azepine derivatives having effects on serotonin related systems
CA 2335310 A1 · Owner: Eli Lilly And Company · Inventors: Hauser, Kenneth Lee; Hertel, Larry Wayne; Xu, Yao-Chang
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides compounds of formula (I) and a method of inhibiting the reuptake of serotonin, antagonizing the 5-HT1A receptor and antagonizing the 5-HT2A receptor which comprises administering to a subject in need of such treatment an effective amount of a compound of formula (I).
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 29, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 29, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 29, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.